Ali Soleymannezhad's most recent trade in MaxCyte Inc was a trade of 1,211 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on March 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | Ali Soleymannezhad | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.18 per share. | 18 Mar 2025 | 1,211 | 59,439 | - | 3.2 | 3,850 | Common Stock |
| MaxCyte Inc | Ali Soleymannezhad | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 138,500 | 138,500 | - | - | Employee Stock Option (right to buy) | |
| MaxCyte Inc | Ali Soleymannezhad | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 34,625 | 60,650 | - | 0 | Common Stock | |
| MaxCyte Inc | Ali Soleymannezhad | Chief Commercial Officer | 16 Sep 2024 | 20,800 | 20,800 | - | - | Employee Stock Option (right to buy) | ||
| MaxCyte Inc | Ali Soleymannezhad | Chief Commercial Officer | 16 Sep 2024 | 10,400 | 26,025 | - | 0 | Common Stock |